Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with progressive atherosclerosis and incident cardiovascular disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 1, 2015, Pages 229-236

  Pechlaner, Raimund ^a   Willeit, Peter ^a,c   Summerer, Monika ^b   Santer, Peter ^b   Egger, Georg ^b   Kronenberg, Florian ^b   Demetz, Egon ^a   Weiss, Günter ^a   Tsimikas, Sotirios ^d   Witztum, Joseph L ^d   Willeit, Karin ^a   Iglseder, Bernhard ^b   Paulweber, Bernhard ^e   Kedenko, Lyudmyla ^e   Haun, Margot ^b   Meisinger, Christa ^b   Gieger, Christian ^b,f   Müller Nurasyid, Martina ^b,g,h   Peters, Annette ^b,h   Willeit, Johann ^a   Kiechl, Stefan ^a   more..

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b San Diego   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Salzburger Landeskliniken   (Austria)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g UNIVERSITY OF MUNICH   (Germany)

^h DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Atherosclerosis; cardiovascular disease; genetic polymorphism; risk factor

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100; HEME OXYGENASE 1; PHOSPHOLIPID; APOB PROTEIN, HUMAN; GENETIC MARKER; HMOX1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; DEATH; DISEASE COURSE; DNA POLYMORPHISM; ECHOGRAPHY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC TRAIT; HEART INFARCTION; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE POLYMORPHISM; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RECESSIVE GENE; SCORING SYSTEM; VARIABLE NUMBER OF TANDEM REPEAT; VASCULAR DEATH; VERY ELDERLY; AUSTRIA; BLOOD; CARDIOVASCULAR DISEASES; ENZYMOLOGY; EPIDEMIOLOGY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HOMOZYGOTE; MIDDLE AGED; MORTALITY; OXIDATION REDUCTION REACTION; PHENOTYPE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN B-100; ATHEROSCLEROSIS; AUSTRIA; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HEME OXYGENASE-1; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MYOCARDIAL INFARCTION; OXIDATION-REDUCTION; PHENOTYPE; PHOSPHOLIPIDS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84920287987     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304729     Document Type: Article

References (34)

1. Ross R. Atherosclerosis-an infammatory disease. N Engl J Med. 1999;340:115-126.
2. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86:583-650.
3. Soares MP, Bach FH. Heme oxygenase-1: from biology to therapeutic potential. Trends Mol Med. 2009;15:50-58.
4. Ishikawa K, Sugawara D, Wang Xp, Suzuki K, Itabe H, Maruyama Y, Lusis AJ. Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res. 2001;88:506-512.
5. Tulis DA, Durante W, Peyton KJ, Evans AJ, Schafer AI. Heme oxy-genase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis. 2001;155:113-122.
6. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med. 2001;7:693-698.
7. Lindenblatt N, Bordel R, Schareck W, Menger MD, Vollmar B. Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo. Arterioscler Thromb Vasc Biol. 2004;24:601-606.
8. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S. Oxidative stress causes enhanced endothe-lial cell injury in human heme oxygenase-1 defciency. J Clin Invest. 1999;103:129-135.
9. Ishikawa K, Navab M, Lusis AJ. Vasculitis, atherosclerosis, and altered HDL composition in heme-oxygenase-1-knockout mice. Int J Hypertens. 2012;2012:948203.
10. Taha H, Skrzypek K, Guevara I, et al. Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol. 2010;30:1634-1641.
11. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, Chau LY. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet. 2002;111:1-8.
12. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, Sasaki H. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet. 2000;66:187-195.
13. Chen M, Zhou L, Ding H, Huang S, He M, Zhang X, Cheng L, Wang D, Hu FB, Wu T. Short (GT) (n) repeats in heme oxygenase-1 gene promoter are associated with lower risk of coronary heart disease in subjects with high levels of oxidative stress. Cell Stress Chaperones. 2012;17:329-338.
14. Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2005;25:1786-1795.
15. Exner M, Schillinger M, Minar E, Mlekusch W, Schlerka G, Haumer M, Mannhalter C, Wagner O. Heme oxygenase-1 gene promoter microsatel-lite polymorphism is associated with restenosis after percutaneous trans-luminal angioplasty. J Endovasc Ther. 2001;8:433-440.
16. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, Nagai R. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol. 2002;22:1680-1685.
17. Schillinger M, Exner M, Mlekusch W, Domanovits H, Huber K, Mannhalter C, Wagner O, Minar E. Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb Res. 2002;106:131-136.
18. Chen YH, Chau LY, Lin MW, Chen LC, Yo MH, Chen JW, Lin SJ. Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur Heart J. 2004;25:39-47.
19. Endler G, Exner M, Schillinger M, Marculescu R, Sunder-Plassmann R, Raith M, Jordanova N, Wojta J, Mannhalter C, Wagner OF, Huber K. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemost. 2004;91:155-161.
20. Funk M, Endler G, Schillinger M, Mustafa S, Hsieh K, Exner M, Lalouschek W, Mannhalter C, Wagner O. The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebro-vascular events: the infuence of other vascular risk factors. Thromb Res. 2004;113:217-223.
21. Schillinger M, Exner M, Minar E, Mlekusch W, Müllner M, Mannhalter C, Bach FH, Wagner O. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol. 2004;43:950-957.
22. Dick P, Schillinger M, Minar E, Mlekusch W, Amighi J, Sabeti S, Schlager O, Raith M, Endler G, Mannhalter C, Wagner O, Exner M. Haem oxygen-ase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease. Eur J Clin Invest. 2005;35:731-737.
23. Gulesserian T, Wenzel C, Endler G, Sunder-Plassmann R, Marsik C, Mannhalter C, Iordanova N, Gyöngyösi M, Wojta J, Mustafa S, Wagner O, Huber K. Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant. Clin Chem. 2005;51:1661-1665.
24. Li P, Elrayess MA, Gomma AH, Palmen J, Hawe E, Fox KM, Humphries SE. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting. Chin Med J (Engl). 2005;118:1525-1532.
25. Wijpkema JS, van Haelst PL, Monraats PS, Bruinenberg M, Zwinderman AH, Zijlstra F, van der Steege G, de Winter RJ, Doevendans PA, Waltenberger J, Jukema JW, Tio RA. Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-con-verting enzyme, angiotensin-II receptor, angiotensinogen or heme oxy-genase-1. Pharmacogenet Genomics. 2006;16:331-337.
26. Tiroch K, Koch W, von Beckerath N, Kastrati A, Schömig A. Heme oxy-genase-1 gene promoter polymorphism and restenosis following coronary stenting. Eur Heart J. 2007;28:968-973.
27. Chen YH, Chau LY, Chen JW, Lin SJ. Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients. Diabetes Care. 2008;31:1615-1620.
28. Lüblinghoff N, Winkler K, Winkelmann BR, Seelhorst U, Wellnitz B, Boehm BO, März W, Hoffmann MM. Genetic variants of the promoter of the heme oxygenase-1 gene and their infuence on cardiovascular disease (the Ludwigshafen Risk and Cardiovascular Health study). BMC Med Genet. 2009;10:36.
29. Bai C-H, Chen J-R, Chiu H-C, Chou C-C, Chau L-Y, Pan W-H. Shorter GT repeat polymorphism in the heme oxygenase-1 gene promoter has protective effect on ischemic stroke in dyslipidemia patients. J Biomed Sci. 2010;17:12.
30. Wu MM, Chiou HY, Chen CL, Wang YH, Hsieh YC, Lien LM, Lee TC, Chen CJ. GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan. Toxicol Appl Pharmacol. 2010;248:226-233.
31. Chen YH, Hung SC, Tarng DC. Length polymorphism in heme oxygen-ase-1 and cardiovascular events and mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8:1756-1763.
32. Gregorek AC, Gornik KC, Polancec DS, Dabelic S. GT microsatellite repeats in the heme oxygenase-1 gene promoter associated with abdominal aortic aneurysm in Croatian patients. Biochem Genet. 2013;51:482-492.
33. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol. 2000;279:L1029-L1037.
34. Romanoski CE, Che N, Yin F, Mai N, Pouldar D, Civelek M, Pan C, Lee S, Vakili L, Yang WP, Kayne P, Mungrue IN, Araujo JA, Berliner JA, Lusis AJ. Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1. Circ Res. 2011;109:e27-e41.